Earli
Adam Bass is responsible for the translation of new oncology science to the clinic at the Dana-Farber Cancer Institute and Harvard, and works with the Broad Institute. As leader of the Gastrointestinal Malignancies Program, he brings together expertise in modern genomics, experimental/functional biology and clinical medicine. Adam has always liked to push the boundaries. After college, he and his friends turned a 1960’s school bus into an RV and drove as far West as they could. The bus broke down in the middle of Utah, but the trip was great.
This person is not in the org chart
This person is not in any offices
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.